drugset / Trial / NCT01647217

Demodex Blepharitis Treatment Study

NCT01647217

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized clinical trial to determine the safety and efficacy of terpinen-4-ol (T4O), the most active ingredient of tea tree oil (TTO), in eradicating ocular demodicosis (reducing ocular demodex counts and achieving the clinical improvement with minimal or no irritation).

Timeline

Start
2014-02
Primary completion
2015-06
Completion
2015-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Terpinen-4-ol Small molecule Topical

Indications